Showing results 1520 to 1539 of 3067
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2013 | Ketamine as a new treatment for depression: a review of its efficacy and adverse effects | Katalinic, K.; Lai, R.; Somogyi, A.; Mitchell, P.; Glue, P.; Loo, C. |
| 2008 | Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS | Lawrinson, P.; Ali, R.; Buarvirat, A.; Chiamwongpaet, S.; Dvoryak, S.; Habrat, B.; Jie, S.; Mardiati, R.; Mokir, A.; Moskalewicz, J.; Newcombe, D.; Poznyak, V.; Subata, E.; Uchtenhagen, A.; Utami, D.; Vial, R.; Zhao, C. |
| 2000 | Kinetics and inhibition of the formation of 6β-naltrexol from naltrexone in human liver cytosol | Porter, S.; Somogyi, A.; White, J. |
| 2010 | Kinetics and regional specificity of irinotecan-induced gene expression in the gastrointestinal tract | Bowen, J.; Tsykin, A.; Stringer, A.; Logan, R.; Gibson, R.; Keefe, D. |
| 2010 | Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury | Thornton, E.; Ziebell, J.; Leonard, A.; Vink, R. |
| 2014 | KRAS G13D mutation and sensitivity to cetuximab or panitumumab in a colorectal cancer cell line model | Sree Kumar, S.; Price, T.; Mohyieldin, O.; Borg, M.; Townsend, A.; Hardingham, J. |
| 2013 | L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial | Ralph, A.; Waramori, G.; Pontororing, G.; Kenangalem, E.; Wiguna, A.; Tjitra, E.; Sandjaja,; Lolong, D.; Yeo, T.; Chatfield, M.; Soemanto, R.; Bastian, I.; Lumb, R.; Maguire, G.; Eisman, J.; Price, R.; Morris, P.; Kelly, P.; Anstey, N.; von Seidlein, L. |
| 2009 | LAAM in the treatment of opioid dependence: a systematic review | Clark, N.; Gijsbers, A.; White, Jason Mark |
| 1995 | Laboratory diagnosis of Mycoplasma pneumoniae infection | Harris, R.; Williamson, J.; Hann, C.; Marmion, B. |
| 2009 | Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRMI) and opioid defendence: A meta-analysis | Coller, J.; Beardsley, J.; Bignold, J.; Li, Y.; Merg, F.; Sullivan, T.; Cox, T.; Somogyi, A. |
| 2007 | Lack of consistency in safe-sleeping messages to parents | Byard, R.; Cains, G.; Noblet, H.; Weber, M. |
| 2008 | Lack of consistency in safe-sleeping messages to parents - Reply | Byard, R.; Cains, G.; Noblet, H.; Weber, M. |
| 2001 | Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects | Moller, S.; Larsen, F.; Khant, A.; Rolan, P. |
| 1995 | Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in human. | Knights, K.; McLean, C.; Tonkin, A.; Miners, J. |
| 2007 | Lack of evidence for a causal relationship between hypoxic-ischemic encephalopathy and subdural hemorrhage in fetal life, infancy, and early childhood | Byard, R.; Blumbergs, P.; Rutty, G.; Sperhake, J.; Banner, J.; Krous, H. |
| 2015 | Lack of evidence for genomic instability in autistic children as measured by the cytokinesis-block micronucleus cytome assay | Main, P.; Thomas, P.; Angley, M.; Young, R.; Esterman, A.; King, C.; Fenech, M. |
| 2016 | Lack of evidence for progression of atherosclerosis during puberty in type 1 diabetes | Peña, A.; Maftei, O.; Harrington, J.; Anderson, J.; Hirte, C.; Gent, R.; Couper, J. |
| 2007 | Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadon | Coller, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A. |
| 2003 | Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects | Ferron, G.; Patat, A.; Parks, V.; Rolan, P.; Troy, S. |
| 1997 | Lack of secular trend in adult stature in white South African males born between 1954 and 1975 | Louw, G.; Henneberg, M. |